Cargando…

The long non-coding RNA Cancer Susceptibility 15 (CASC15) is induced by isocitrate dehydrogenase (IDH) mutations and maintains an immature phenotype in adult acute myeloid leukemia

Detalles Bibliográficos
Autores principales:	Grasedieck, Sarah, Ruess, Christoph, Krowiorz, Kathrin, Lux, Susanne, Pochert, Nicole, Schwarzer, Adrian, Klusmann, Jan-Henning, Jongen-Lavrencic, Mojca, Herold, Tobias, Bullinger, Lars, Pollack, Jonathan R., Rouhi, Arefeh, Kuchenbauer, Florian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Fondazione Ferrata Storti 2020
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556616/ https://www.ncbi.nlm.nih.gov/pubmed/33054061 http://dx.doi.org/10.3324/haematol.2019.235291

Ejemplares similares

Circular RNAs of the nucleophosmin (NPM1) gene in acute myeloid leukemia
por: Hirsch, Susanne, et al.
Publicado: (2017)

The retinoic acid receptor co-factor NRIP1 is uniquely upregulated and represents a therapeutic target in acute myeloid leukemia with chromosome 3q rearrangements
por: Grasedieck, Sarah, et al.
Publicado: (2021)

Prospective identification of resistance mechanisms to HSP90 inhibition in KRAS mutant cancer cells
por: Rouhi, Arefeh, et al.
Publicado: (2016)

The non-coding RNA landscape of human hematopoiesis and leukemia
por: Schwarzer, Adrian, et al.
Publicado: (2017)

CASC15 gene polymorphisms reduce neuroblastoma risk in Chinese children
por: Zhang, Jiao, et al.
Publicado: (2017)

CASC15 polymorphisms are correlated with cervical cancer susceptibility in Chinese women
por: Gao, Ziying, et al.
Publicado: (2020)

Isocitrate Dehydrogenase IDH1 and IDH2 Mutations in Human Cancer: Prognostic Implications for Gliomas
por: Murugan, A. K., et al.
Publicado: (2022)

LncRNA CASC15 is Upregulated in Osteosarcoma Plasma Exosomes and CASC15 Knockdown Inhibits Osteosarcoma Progression by Regulating miR-338-3p/RAB14 Axis
por: Zhang, Hongliang, et al.
Publicado: (2020)

Mismatch repair protein mutations in isocitrate dehydrogenase (IDH)-mutant astrocytoma and IDH-wild-type glioblastoma
por: Richardson, Timothy E, et al.
Publicado: (2023)

Exploiting Electrode Nanoconfinement to Investigate the Catalytic Properties of Isocitrate Dehydrogenase (IDH1) and a Cancer-Associated Variant
por: Herold, Ryan A., et al.
Publicado: (2021)

Mutated Isocitrate Dehydrogenase (mIDH) as Target for PET Imaging in Gliomas
por: Neumaier, Felix, et al.
Publicado: (2023)

Metabolic characterization of isocitrate dehydrogenase (IDH) mutant and IDH wildtype gliomaspheres uncovers cell type-specific vulnerabilities
por: Garrett, Matthew, et al.
Publicado: (2018)

Expression of CD133 Cancer Stem Cell Marker in IDH-Mutant and IDH-wildtype (Isocitrate Dehydrogenase) Astrocytoma
por: Sabunga, Olivia Desty, et al.
Publicado: (2022)

Micro-ribonucleic acid-155 is a direct target of Meis1, but not a driver in acute myeloid leukemia
por: Schneider, Edith, et al.
Publicado: (2018)

Isocitrate protects DJ-1 null dopaminergic cells from oxidative stress through NADP(+)-dependent isocitrate dehydrogenase (IDH)
por: Yang, Jinsung, et al.
Publicado: (2017)

Long non-coding RNA CASC15 is upregulated in hepatocellular carcinoma and facilitates hepatocarcinogenesis
por: He, Tianyu, et al.
Publicado: (2017)

Isocitrate Dehydrogenase (IDH)1/2 Mutations as Prognostic Markers in Patients With Glioblastomas
por: Chen, Jun-Rui, et al.
Publicado: (2016)

Identification of Isocitrate Dehydrogenase 2 (IDH2) Mutation in Carotid Body Paraganglioma
por: Lang, Fengchao, et al.
Publicado: (2021)

The prognostic significance of wild-type isocitrate dehydrogenase 2 (IDH2) in breast cancer
por: Aljohani, Abrar I., et al.
Publicado: (2019)

Isocitrate dehydrogenase (IDH) status prediction in histopathology images of gliomas using deep learning
por: Liu, Sidong, et al.
Publicado: (2020)

The versatile nature of miR-9/9(*) in human cancer
por: Nowek, Katarzyna, et al.
Publicado: (2018)

Early volumetric, perfusion, and diffusion MRI changes after mutant isocitrate dehydrogenase (IDH) inhibitor treatment in IDH1-mutant gliomas
por: Cho, Nicholas S, et al.
Publicado: (2022)

The CASC15 long intergenic non-coding RNA locus is involved in melanoma progression and phenotype-switching
por: Lessard, Laurent, et al.
Publicado: (2015)

Long non-coding RNA CASC15 promotes melanoma progression by epigenetically regulating PDCD4
por: Yin, Yakun, et al.
Publicado: (2018)

The lncRNA CASC15 regulates SOX4 expression in RUNX1-rearranged acute leukemia
por: Fernando, Thilini R., et al.
Publicado: (2017)

CircCASC15-miR-100-mTOR may influence the cervical cancer radioresistance
por: Yao, Tingting, et al.
Publicado: (2022)

Prognostic value of CASC15 and LINC01600 as competitive endogenous RNAs in lung adenocarcinoma: An observational study
por: Zhou, Fangbin
Publicado: (2023)

Downregulation of long noncoding RNA CASC15 inhibits progression, migration and invasion of papillary thyroid cancer
por: Li, Xiaoyu, et al.
Publicado: (2019)

Aberrant long non-coding RNA cancer susceptibility 15 (CASC15) plays a diagnostic biomarker and regulates inflammatory reaction in neonatal sepsis
por: Song, Jia, et al.
Publicado: (2021)

An Analysis of the Prognostic Value of IDH1 (Isocitrate Dehydrogenase 1) Mutation in Polish Glioma Patients
por: Lewandowska, Marzena Anna, et al.
Publicado: (2013)

Radiological Prediction of Isocitrate Dehydrogenase (IDH) Mutational Status and Pathological Verification for Lower-Grade Astrocytomas
por: Yano, Hirohito, et al.
Publicado: (2022)

Isocitrate dehydrogenase 1 (IDH1) mutation-specific microRNA signature predicts favorable prognosis in glioblastoma patients with IDH1 wild type
por: Wang, Zheng, et al.
Publicado: (2013)

Detection Of Mutations In The Isocitrate Dehydrogenase Genes (IDH1/IDH2) Using castPCR(TM) In Patients With AML And Their Clinical Impact In Mexico City
por: Olarte, Irma, et al.
Publicado: (2019)

Functional alteration of canine isocitrate dehydrogenase 2 (IDH2) via an R174K mutation
por: KAWAKAMI, Shota, et al.
Publicado: (2017)

Association of Isocitrate Dehydrogenase (IDH) Status With Edema to Tumor Ratio and Its Correlation With Immune Infiltration in Glioblastoma
por: Dubinski, Daniel, et al.
Publicado: (2021)

Profiling the Effect of Targeting Wild Isocitrate Dehydrogenase 1 (IDH1) on the Cellular Metabolome of Leukemic Cells
por: Shait Mohammed, Mohammed Razeeth, et al.
Publicado: (2022)

Glioma immunotherapy enhancement and CD8-specific sialic acid cleavage by isocitrate dehydrogenase (IDH)-1
por: Cordner, Ryan, et al.
Publicado: (2023)

MiR-139-5p is a potent tumor suppressor in adult acute myeloid leukemia
por: Krowiorz, K, et al.
Publicado: (2016)

NBAT1/CASC15-003/USP36 control MYCN expression and its downstream pathway genes in neuroblastoma
por: Juvvuna, Prasanna Kumar, et al.
Publicado: (2021)

An innovative CASC training redesign – ‘experience of virtual mock CASC exam’
por: Rankin, Jennifer, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p5o41mt2qbrtckbipgl0oa9e4t